Alan Schatzberg - Publications

Affiliations: 
Psychiatry Stanford University, Palo Alto, CA 

273 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Heifets BD, Williams NR, Blasey C, Sudheimer K, Rodriguez CI, Schatzberg AF. Interpreting Ketamine's Opioid Receptor Dependent Effect: Response to Sanacora. The American Journal of Psychiatry. 176: 249-250. PMID 30818991 DOI: 10.1176/appi.ajp.2018.18091061r  0.36
2019 Heifets BD, Williams NR, Blasey C, Sudheimer K, Rodriguez CI, Schatzberg AF. Target Population, Dose, and Timing Considerations for Understanding Naltrexone's Subjective Effect: Response to Amiaz. The American Journal of Psychiatry. 176: 251-252. PMID 30818989 DOI: 10.1176/appi.ajp.2018.18111231r  0.36
2019 Meyer BM, Rabl U, Huemer J, Bartova L, Kalcher K, Provenzano J, Brandner C, Sezen P, Kasper S, Schatzberg AF, Moser E, Chen G, Pezawas L. Prefrontal networks dynamically related to recovery from major depressive disorder: a longitudinal pharmacological fMRI study. Translational Psychiatry. 9: 64. PMID 30718459 DOI: 10.1038/s41398-019-0395-8  0.6
2019 Fava M, Freeman MP, Flynn M, Judge H, Hoeppner BB, Cusin C, Ionescu DF, Mathew SJ, Chang LC, Iosifescu DV, Murrough J, Debattista C, Schatzberg AF, Trivedi MH, Jha MK, et al. Correction: Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD). Molecular Psychiatry. PMID 30617276 DOI: 10.1038/s41380-018-0311-2  0.52
2018 Fava M, Freeman MP, Flynn M, Judge H, Hoeppner BB, Cusin C, Ionescu DF, Mathew SJ, Chang LC, Iosifescu DV, Murrough J, Debattista C, Schatzberg AF, Trivedi MH, Jha MK, et al. Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD). Molecular Psychiatry. PMID 30283029 DOI: 10.1038/s41380-018-0256-5  0.52
2018 Williams NR, Heifets BD, Blasey C, Sudheimer K, Pannu J, Pankow H, Hawkins J, Birnbaum J, Lyons DM, Rodriguez CI, Schatzberg AF. Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism. The American Journal of Psychiatry. appiajp201818020138. PMID 30153752 DOI: 10.1176/appi.ajp.2018.18020138  0.36
2018 Williams NR, Sudheimer KD, Bentzley BS, Pannu J, Stimpson KH, Duvio D, Cherian K, Hawkins J, Scherrer KH, Vyssoki B, DeSouza D, Raj KS, Keller J, Schatzberg AF. High-dose spaced theta-burst TMS as a rapid-acting antidepressant in highly refractory depression. Brain : a Journal of Neurology. PMID 29415152 DOI: 10.1093/brain/awx379  0.36
2018 Davis EG, Keller J, Hallmayer J, Pankow HR, Murphy GM, Gotlib IH, Schatzberg AF. Corticotropin-releasing factor 1 receptor haplotype and cognitive features of major depression. Translational Psychiatry. 8: 5. PMID 29317606 DOI: 10.1038/s41398-017-0051-0  0.32
2017 O'Connell CP, Goldstein-Piekarski AN, Nemeroff CB, Schatzberg AF, Debattista C, Carrillo-Roa T, Binder EB, Dunlop BW, Craighead WE, Mayberg HS, Williams LM. Antidepressant Outcomes Predicted by Genetic Variation in Corticotropin-Releasing Hormone Binding Protein. The American Journal of Psychiatry. appiajp201717020172. PMID 29241359 DOI: 10.1176/appi.ajp.2017.17020172  0.52
2017 Sanacora G, Frye MA, McDonald W, Mathew SJ, Turner MS, Schatzberg AF, Summergrad P, Nemeroff CB. A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders. Jama Psychiatry. PMID 28249076 DOI: 10.1001/jamapsychiatry.2017.0080  0.32
2017 Drysdale AT, Grosenick L, Downar J, Dunlop K, Mansouri F, Meng Y, Fetcho RN, Zebley B, Oathes DJ, Etkin A, Schatzberg AF, Sudheimer K, Keller J, Mayberg HS, Gunning FM, et al. Erratum: Resting-state connectivity biomarkers define neurophysiological subtypes of depression. Nature Medicine. 23: 264. PMID 28170383 DOI: 10.1038/nm0217-264d  1
2016 Drysdale AT, Grosenick L, Downar J, Dunlop K, Mansouri F, Meng Y, Fetcho RN, Zebley B, Oathes DJ, Etkin A, Schatzberg AF, Sudheimer K, Keller J, Mayberg HS, Gunning FM, et al. Resting-state connectivity biomarkers define neurophysiological subtypes of depression. Nature Medicine. PMID 27918562 DOI: 10.1038/nm.4246  1
2016 Goldstein-Piekarski AN, Korgaonkar MS, Green E, Suppes T, Schatzberg AF, Hastie T, Nemeroff CB, Williams LM. Human amygdala engagement moderated by early life stress exposure is a biobehavioral target for predicting recovery on antidepressants. Proceedings of the National Academy of Sciences of the United States of America. 113: 11955-11960. PMID 27791054 DOI: 10.1073/pnas.1606671113  0.52
2016 Otte C, Gold SM, Penninx BW, Pariante CM, Etkin A, Fava M, Mohr DC, Schatzberg AF. Major depressive disorder. Nature Reviews. Disease Primers. 2: 16065. PMID 27629598 DOI: 10.1038/nrdp.2016.65  1
2016 Azevedo JA, Carter BS, Meng F, Turner DL, Dai M, Schatzberg AF, Barchas JD, Jones EG, Bunney WE, Myers RM, Akil H, Watson SJ, Thompson RC. The microRNA network is altered in anterior cingulate cortex of patients with unipolar and bipolar depression. Journal of Psychiatric Research. 82: 58-67. PMID 27468165 DOI: 10.1016/j.jpsychires.2016.07.012  1
2016 Newport DJ, Schatzberg AF, Nemeroff CB. WHITHER KETAMINE AS AN ANTIDEPRESSANT: PANACEA OR TOXIN? Depression and Anxiety. 33: 685-8. PMID 27459676 DOI: 10.1002/da.22535  0.32
2016 Krystal JH, Abi-Dargham A, Akbarian S, Arnsten AF, Barch DM, Bearden CE, Braff DL, Brown ES, Bullmore ET, Carlezon WA, Carter CS, Cook EH, Daskalakis ZJ, DiLeone RJ, Duman RS, ... ... Schatzberg AF, et al. Constance E. Lieber, Theodore R. Stanley, and the Enduring Impact of Philanthropy on Psychiatry Research. Biological Psychiatry. 80: 84-6. PMID 27346079 DOI: 10.1016/j.biopsych.2016.05.004  1
2016 Lee AG, Capanzana R, Brockhurst J, Cheng MY, Buckmaster CL, Absher D, Schatzberg AF, Lyons DM. Learning to cope with stress modulates anterior cingulate cortex stargazin expression in monkeys and mice. Neurobiology of Learning and Memory. PMID 27003116 DOI: 10.1016/j.nlm.2016.03.015  1
2016 Williams LM, Goldstein-Piekarski AN, Chowdhry N, Grisanzio KA, Haug NA, Samara Z, Etkin A, O'Hara R, Schatzberg AF, Suppes T, Yesavage J. Developing a clinical translational neuroscience taxonomy for anxiety and mood disorder: protocol for the baseline-follow up Research domain criteria Anxiety and Depression ("RAD") project. Bmc Psychiatry. 16: 68. PMID 26980207 DOI: 10.1186/s12888-016-0771-3  1
2015 Williams NR, Schatzberg AF. NMDA antagonist treatment of depression. Current Opinion in Neurobiology. 36: 112-117. PMID 26687375 DOI: 10.1016/j.conb.2015.11.001  1
2015 Medina A, Watson SJ, Bunney W, Myers RM, Schatzberg A, Barchas J, Akil H, Thompson RC. Evidence for alterations of the glial syncytial function in major depressive disorder. Journal of Psychiatric Research. 72: 15-21. PMID 26519765 DOI: 10.1016/j.jpsychires.2015.10.010  1
2015 Aurbach EL, Inui EG, Turner CA, Hagenauer MH, Prater KE, Li JZ, Absher D, Shah N, Blandino P, Bunney WE, Myers RM, Barchas JD, Schatzberg AF, Watson SJ, Akil H. Fibroblast growth factor 9 is a novel modulator of negative affect. Proceedings of the National Academy of Sciences of the United States of America. 112: 11953-8. PMID 26351673 DOI: 10.1073/pnas.1510456112  1
2015 Schatzberg AF. Development of New Psychopharmacological Agents for Depression and Anxiety. The Psychiatric Clinics of North America. 38: 379-93. PMID 26300029 DOI: 10.1016/j.psc.2015.05.009  1
2015 Kupfer DJ, Schatzberg AF, Dunn LO, Schneider AK, Moore TL, DeRosier M. Career Development Institute with Enhanced Mentoring: A Revisit. Academic Psychiatry : the Journal of the American Association of Directors of Psychiatric Residency Training and the Association For Academic Psychiatry. PMID 26048460 DOI: 10.1007/s40596-015-0362-5  1
2015 Sequeira A, Rollins B, Magnan C, van Oven M, Baldi P, Myers RM, Barchas JD, Schatzberg AF, Watson SJ, Akil H, Bunney WE, Vawter MP. Mitochondrial mutations in subjects with psychiatric disorders. Plos One. 10: e0127280. PMID 26011537 DOI: 10.1371/journal.pone.0127280  1
2015 Schatzberg A. The chicken and egg of anxiety and depression. Epidemiology and Psychiatric Sciences. 24: 227-9. PMID 25997897 DOI: 10.1017/S2045796015000219  1
2015 Schatzberg AF, DeBattista C, Lazzeroni LC, Etkin A, Murphy GM, Williams LM. ABCB1 Genetic Effects on Antidepressant Outcomes: A Report From the iSPOT-D Trial. The American Journal of Psychiatry. appiajp201514050680. PMID 25815420 DOI: 10.1176/appi.ajp.2015.14050680  1
2015 Arnow BA, Blasey C, Williams LM, Palmer DM, Rekshan W, Schatzberg AF, Etkin A, Kulkarni J, Luther JF, Rush AJ. Depression Subtypes in Predicting Antidepressant Response: A Report From the iSPOT-D Trial. The American Journal of Psychiatry. appiajp201514020181. PMID 25815419 DOI: 10.1176/appi.ajp.2015.14020181  1
2015 Schatzberg AF. Issues encountered in recent attempts to develop novel antidepressant agents. Annals of the New York Academy of Sciences. 1345: 67-73. PMID 25762133 DOI: 10.1111/nyas.12716  1
2015 Day CV, Gatt JM, Etkin A, DeBattista C, Schatzberg AF, Williams LM. Cognitive and emotional biomarkers of melancholic depression: An iSPOT-D report. Journal of Affective Disorders. 176: 141-50. PMID 25710095 DOI: 10.1016/j.jad.2015.01.061  1
2015 Saveanu R, Etkin A, Duchemin AM, Goldstein-Piekarski A, Gyurak A, Debattista C, Schatzberg AF, Sood S, Day CV, Palmer DM, Rekshan WR, Gordon E, Rush AJ, Williams LM. The international Study to Predict Optimized Treatment in Depression (iSPOT-D): outcomes from the acute phase of antidepressant treatment. Journal of Psychiatric Research. 61: 1-12. PMID 25586212 DOI: 10.1016/j.jpsychires.2014.12.018  1
2015 Sarginson JE, Killen JD, Lazzeroni LC, Fortmann SP, Ryan HS, Ameli N, Schatzberg AF, Murphy GM. Response to Transdermal Selegiline Smoking Cessation Therapy and Markers in the 15q24 Chromosomal Region. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 25572450 DOI: 10.1093/ntr/ntu273  1
2015 Day CV, John Rush A, Harris AW, Boyce PM, Rekshan W, Etkin A, DeBattista C, Schatzberg AF, Arnow BA, Williams LM. Impairment and distress patterns distinguishing the melancholic depression subtype: an iSPOT-D report. Journal of Affective Disorders. 174: 493-502. PMID 25554994 DOI: 10.1016/j.jad.2014.10.046  1
2015 Etkin A, Patenaude B, Song YJ, Usherwood T, Rekshan W, Schatzberg AF, Rush AJ, Williams LM. A cognitive-emotional biomarker for predicting remission with antidepressant medications: a report from the iSPOT-D trial. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 40: 1332-42. PMID 25547711 DOI: 10.1038/npp.2014.333  1
2015 Oathes DJ, Patenaude B, Schatzberg AF, Etkin A. Neurobiological signatures of anxiety and depression in resting-state functional magnetic resonance imaging. Biological Psychiatry. 77: 385-93. PMID 25444162 DOI: 10.1016/j.biopsych.2014.08.006  1
2015 Bunney BG, Li JZ, Walsh DM, Stein R, Vawter MP, Cartagena P, Barchas JD, Schatzberg AF, Myers RM, Watson SJ, Akil H, Bunney WE. Circadian dysregulation of clock genes: clues to rapid treatments in major depressive disorder. Molecular Psychiatry. 20: 48-55. PMID 25349171 DOI: 10.1038/mp.2014.138  1
2015 Sudheimer K, Keller J, Gomez R, Tennakoon L, Reiss A, Garrett A, Kenna H, O'Hara R, Schatzberg AF. Decreased hypothalamic functional connectivity with subgenual cortex in psychotic major depression. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 40: 849-60. PMID 25292261 DOI: 10.1038/npp.2014.259  1
2015 Schatzberg AF. Anna-Monika Award Lecture, DGPPN Kongress, 2013: the role of the hypothalamic-pituitary-adrenal (HPA) axis in the pathogenesis of psychotic major depression. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 16: 2-11. PMID 24933348 DOI: 10.3109/15622975.2014.916414  1
2015 Thompson DG, Kesler SR, Sudheimer K, Mehta KM, Thompson LW, Marquett RM, Holland JM, Reiser R, Rasgon N, Schatzberg A, O'Hara RM. FMRI activation during executive function predicts response to cognitive behavioral therapy in older, depressed adults. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 23: 13-22. PMID 24656506 DOI: 10.1016/j.jagp.2014.02.001  1
2014 Schatzberg AF, Blier P, Culpepper L, Jain R, Papakostas GI, Thase ME. An overview of vortioxetine. The Journal of Clinical Psychiatry. 75: 1411-8. PMID 25551236 DOI: 10.4088/JCP.14027ah1  1
2014 Ray A, Tennakoon L, Keller J, Sarginson JE, Ryan HS, Murphy GM, Lazzeroni LC, Trivedi MH, Kocsis JH, DeBattista C, Schatzberg AF. ABCB1 (MDR1) predicts remission on P-gp substrates in chronic depression. The Pharmacogenomics Journal. PMID 25487678 DOI: 10.1038/tpj.2014.72  1
2014 Lee MS, Kim YH, Park WS, Park OK, Kwon SH, Hong KS, Rhim H, Shim I, Morita K, Wong DL, Patel PD, Lyons DM, Schatzberg AF, Her S. Temporal variability of glucocorticoid receptor activity is functionally important for the therapeutic action of fluoxetine in the hippocampus. Molecular Psychiatry. PMID 25330740 DOI: 10.1038/mp.2014.137  1
2014 Lee AG, Buckmaster CL, Yi E, Schatzberg AF, Lyons DM. Coping and glucocorticoid receptor regulation by stress inoculation. Psychoneuroendocrinology. 49: 272-9. PMID 25127085 DOI: 10.1016/j.psyneuen.2014.07.020  1
2014 Reich J, Schatzberg A. An empirical data comparison of regulatory agency and malpractice legal problems for psychiatrists. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 26: 91-6. PMID 24812648  1
2014 Turner CA, Thompson RC, Bunney WE, Schatzberg AF, Barchas JD, Myers RM, Akil H, Watson SJ. Altered choroid plexus gene expression in major depressive disorder. Frontiers in Human Neuroscience. 8: 238. PMID 24795602 DOI: 10.3389/fnhum.2014.00238  1
2014 Schatzberg AF. A word to the wise about ketamine. The American Journal of Psychiatry. 171: 262-4. PMID 24585328 DOI: 10.1176/appi.ajp.2014.13101434  1
2014 Yuen KW, Garner JP, Carson DS, Keller J, Lembke A, Hyde SA, Kenna HA, Tennakoon L, Schatzberg AF, Parker KJ. Plasma oxytocin concentrations are lower in depressed vs. healthy control women and are independent of cortisol. Journal of Psychiatric Research. 51: 30-6. PMID 24405552 DOI: 10.1016/j.jpsychires.2013.12.012  1
2014 Schatzberg AF, Keller J, Tennakoon L, Lembke A, Williams G, Kraemer FB, Sarginson JE, Lazzeroni LC, Murphy GM. HPA axis genetic variation, cortisol and psychosis in major depression. Molecular Psychiatry. 19: 220-7. PMID 24166410 DOI: 10.1038/mp.2013.129  1
2014 Holland JM, Rozalski V, Thompson KL, Tiongson RJ, Schatzberg AF, O'Hara R, Gallagher-Thompson D. The unique impact of late-life bereavement and prolonged grief on diurnal cortisol. The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences. 69: 4-11. PMID 23740094 DOI: 10.1093/geronb/gbt051  1
2013 Tomita H, Ziegler ME, Kim HB, Evans SJ, Choudary PV, Li JZ, Meng F, Dai M, Myers RM, Neal CR, Speed TP, Barchas JD, Schatzberg AF, Watson SJ, Akil H, et al. G protein-linked signaling pathways in bipolar and major depressive disorders. Frontiers in Genetics. 4: 297. PMID 24391664 DOI: 10.3389/fgene.2013.00297  1
2013 Holland JM, Schatzberg AF, O'Hara R, Marquett RM, Gallagher-Thompson D. Pretreatment cortisol levels predict posttreatment outcomes among older adults with depression in cognitive behavioral therapy. Psychiatry Research. 210: 444-50. PMID 23953171 DOI: 10.1016/j.psychres.2013.07.033  1
2013 Grieve SM, Korgaonkar MS, Etkin A, Harris A, Koslow SH, Wisniewski S, Schatzberg AF, Nemeroff CB, Gordon E, Williams LM. Brain imaging predictors and the international study to predict optimized treatment for depression: study protocol for a randomized controlled trial. Trials. 14: 224. PMID 23866851 DOI: 10.1186/1745-6215-14-224  1
2013 Guella I, Sequeira A, Rollins B, Morgan L, Torri F, van Erp TG, Myers RM, Barchas JD, Schatzberg AF, Watson SJ, Akil H, Bunney WE, Potkin SG, Macciardi F, Vawter MP. Analysis of miR-137 expression and rs1625579 in dorsolateral prefrontal cortex. Journal of Psychiatric Research. 47: 1215-21. PMID 23786914 DOI: 10.1016/j.jpsychires.2013.05.021  1
2013 Medina A, Burke S, Thompson RC, Bunney W, Myers RM, Schatzberg A, Akil H, Watson SJ. Glutamate transporters: a key piece in the glutamate puzzle of major depressive disorder. Journal of Psychiatric Research. 47: 1150-6. PMID 23706640 DOI: 10.1016/j.jpsychires.2013.04.007  1
2013 Li JZ, Bunney BG, Meng F, Hagenauer MH, Walsh DM, Vawter MP, Evans SJ, Choudary PV, Cartagena P, Barchas JD, Schatzberg AF, Jones EG, Myers RM, Watson SJ, Akil H, et al. Circadian patterns of gene expression in the human brain and disruption in major depressive disorder. Proceedings of the National Academy of Sciences of the United States of America. 110: 9950-5. PMID 23671070 DOI: 10.1073/pnas.1305814110  1
2013 Murphy GM, Sarginson JE, Ryan HS, O'Hara R, Schatzberg AF, Lazzeroni LC. BDNF and CREB1 genetic variants interact to affect antidepressant treatment outcomes in geriatric depression. Pharmacogenetics and Genomics. 23: 301-13. PMID 23619509 DOI: 10.1097/FPC.0b013e328360b175  1
2013 Cohen JD, Nichols T, Keller J, Gomez RG, Schatzberg AF, Reiss AL. Insular cortex abnormalities in psychotic major depression: relationship to gender and psychotic symptoms. Neuroscience Research. 75: 331-9. PMID 23471015 DOI: 10.1016/j.neures.2013.02.005  1
2013 Medina A, Seasholtz AF, Sharma V, Burke S, Bunney W, Myers RM, Schatzberg A, Akil H, Watson SJ. Glucocorticoid and mineralocorticoid receptor expression in the human hippocampus in major depressive disorder. Journal of Psychiatric Research. 47: 307-14. PMID 23219281 DOI: 10.1016/j.jpsychires.2012.11.002  1
2013 Kelley R, Garrett A, Cohen J, Gomez R, Lembke A, Keller J, Reiss AL, Schatzberg A. Altered brain function underlying verbal memory encoding and retrieval in psychotic major depression. Psychiatry Research. 211: 119-26. PMID 23149036 DOI: 10.1016/j.pscychresns.2012.06.008  1
2013 Lembke A, Gomez R, Tenakoon L, Keller J, Cohen G, Williams GH, Kraemer FB, Schatzberg AF. The mineralocorticoid receptor agonist, fludrocortisone, differentially inhibits pituitary-adrenal activity in humans with psychotic major depression. Psychoneuroendocrinology. 38: 115-21. PMID 22727477 DOI: 10.1016/j.psyneuen.2012.05.006  1
2012 Parker KJ, Buckmaster CL, Lindley SE, Schatzberg AF, Lyons DM. Hypothalamic-pituitary-adrenal axis physiology and cognitive control of behavior in stress inoculated monkeys. International Journal of Behavioral Development. 36. PMID 24353360 DOI: 10.1177/0165025411406864  1
2012 Kerman IA, Bernard R, Bunney WE, Jones EG, Schatzberg AF, Myers RM, Barchas JD, Akil H, Watson SJ, Thompson RC. Evidence for transcriptional factor dysregulation in the dorsal raphe nucleus of patients with major depressive disorder. Frontiers in Neuroscience. 6: 135. PMID 23087602 DOI: 10.3389/fnins.2012.00135  1
2012 Sequeira A, Morgan L, Walsh DM, Cartagena PM, Choudary P, Li J, Schatzberg AF, Watson SJ, Akil H, Myers RM, Jones EG, Bunney WE, Vawter MP. Gene expression changes in the prefrontal cortex, anterior cingulate cortex and nucleus accumbens of mood disorders subjects that committed suicide. Plos One. 7: e35367. PMID 22558144 DOI: 10.1371/journal.pone.0035367  1
2012 Che AM, Gomez RG, Keller J, Lembke A, Tennakoon L, Cohen GH, Schatzberg AF. The relationships of positive and negative symptoms with neuropsychological functioning and their ability to predict verbal memory in psychotic major depression. Psychiatry Research. 198: 34-8. PMID 22410589 DOI: 10.1016/j.psychres.2011.12.001  1
2012 Buckley TM, Mullen BC, Schatzberg AF. Corrigendum to 'The acute effects of a mineralocorticoid receptor (MR) agonist on nocturnal hypothalamic-adrenal-pituitary (HPA) axis activity in healthy controls' [Psychoneuroendocrinology (2007) 859-864] Psychoneuroendocrinology. 37: 586. DOI: 10.1016/j.psyneuen.2012.01.010  1
2012 Kessler RC, Schatzberg AF. Commentary on Abortion Studies of Steinberg and Finer (Social Science & Medicine 2011; 72:72-82) and Coleman (Journal of Psychiatric Research 2009;43:770-6 & Journal of Psychiatric Research 2011;45:1133-4) Journal of Psychiatric Research. 46: 410-411. DOI: 10.1016/j.jpsychires.2012.01.021  1
2011 Moon E, Rollins B, Mesén A, Sequeira A, Myers RM, Akil H, Watson SJ, Barchas J, Jones EG, Schatzberg A, Bunney WE, DeLisi LE, Byerley W, Vawter MP. Lack of association to a NRG1 missense polymorphism in schizophrenia or bipolar disorder in a Costa Rican population. Schizophrenia Research. 131: 52-7. PMID 21745728 DOI: 10.1016/j.schres.2011.06.024  1
2011 Etkin A, Schatzberg AF. Common abnormalities and disorder-specific compensation during implicit regulation of emotional processing in generalized anxiety and major depressive disorders. The American Journal of Psychiatry. 168: 968-78. PMID 21632648 DOI: 10.1176/appi.ajp.2011.10091290  1
2011 Wade AG, Crawford GM, Nemeroff CB, Schatzberg AF, Schlaepfer T, McConnachie A, Haazen L, Buntinx E. Citalopram plus low-dose pipamperone versus citalopram plus placebo in patients with major depressive disorder: an 8-week, double-blind, randomized study on magnitude and timing of clinical response. Psychological Medicine. 41: 2089-97. PMID 21349239 DOI: 10.1017/S0033291711000158  1
2011 Sarginson JE, Killen JD, Lazzeroni LC, Fortmann SP, Ryan HS, Schatzberg AF, Murphy GM. Markers in the 15q24 nicotinic receptor subunit gene cluster (CHRNA5-A3-B4) predict severity of nicotine addiction and response to smoking cessation therapy. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 156: 275-84. PMID 21268243 DOI: 10.1002/ajmg.b.31155  1
2011 Williams LM, Rush AJ, Koslow SH, Wisniewski SR, Cooper NJ, Nemeroff CB, Schatzberg AF, Gordon E. International Study to Predict Optimized Treatment for Depression (iSPOT-D), a randomized clinical trial: rationale and protocol. Trials. 12: 4. PMID 21208417 DOI: 10.1186/1745-6215-12-4  1
2011 Garrett A, Kelly R, Gomez R, Keller J, Schatzberg AF, Reiss AL. Aberrant brain activation during a working memory task in psychotic major depression. The American Journal of Psychiatry. 168: 173-82. PMID 21078708 DOI: 10.1176/appi.ajp.2010.09121718  1
2011 Parker KJ, Hyde SA, Buckmaster CL, Tanaka SM, Brewster KK, Schatzberg AF, Lyons DM, Woodward SH. Somatic and neuroendocrine responses to standard and biologically salient acoustic startle stimuli in monkeys. Psychoneuroendocrinology. 36: 547-56. PMID 20869176 DOI: 10.1016/j.psyneuen.2010.08.009  1
2011 Bernard R, Kerman IA, Thompson RC, Jones EG, Bunney WE, Barchas JD, Schatzberg AF, Myers RM, Akil H, Watson SJ. Altered expression of glutamate signaling, growth factor, and glia genes in the locus coeruleus of patients with major depression. Molecular Psychiatry. 16: 634-46. PMID 20386568 DOI: 10.1038/mp.2010.44  1
2011 Schatzberg AF. An Applied Context for Personalized Medicine in Psychiatry Integrative Neuroscience and Personalized Medicine. DOI: 10.1093/acprof:oso/9780195393804.003.0002  1
2011 Schatzberg AF, Holsboer F. The journal of psychiatric research celebrates its 50th anniversary in 2011 Journal of Psychiatric Research. 45: 5-6. DOI: 10.1016/j.jpsychires.2010.12.001  1
2010 Janicak PG, Nahas Z, Lisanby SH, Solvason HB, Sampson SM, McDonald WM, Marangell LB, Rosenquist P, McCall WV, Kimball J, O'Reardon JP, Loo C, Husain MH, Krystal A, Gilmer W, ... ... Schatzberg AF, et al. Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study. Brain Stimulation. 3: 187-99. PMID 20965447 DOI: 10.1016/j.brs.2010.07.003  1
2010 Lyons DM, Parker KJ, Schatzberg AF. Animal models of early life stress: implications for understanding resilience. Developmental Psychobiology. 52: 616-24. PMID 20957724 DOI: 10.1002/dev.20500  1
2010 Lindley S, Cacciapaglia H, Noronha D, Carlson E, Schatzberg A. Monitoring mental health treatment acceptance and initial treatment adherence in veterans: veterans of Operations Enduring Freedom and Iraqi Freedom versus other veterans of other eras. Annals of the New York Academy of Sciences. 1208: 104-13. PMID 20955332 DOI: 10.1111/j.1749-6632.2010.05692.x  1
2010 Schatzberg AF. Presidential address. The American Journal of Psychiatry. 167: 1161-5. PMID 20889661 DOI: 10.1176/appi.ajp.2010.167.10.1161  1
2010 Krolewski DM, Medina A, Kerman IA, Bernard R, Burke S, Thompson RC, Bunney WE, Schatzberg AF, Myers RM, Akil H, Jones EG, Watson SJ. Expression patterns of corticotropin-releasing factor, arginine vasopressin, histidine decarboxylase, melanin-concentrating hormone, and orexin genes in the human hypothalamus. The Journal of Comparative Neurology. 518: 4591-611. PMID 20886624 DOI: 10.1002/cne.22480  1
2010 Killen JD, Fortmann SP, Murphy GM, Hayward C, Fong D, Lowenthal K, Bryson SW, Killen DT, Schatzberg AF. Failure to improve cigarette smoking abstinence with transdermal selegiline + cognitive behavior therapy. Addiction (Abingdon, England). 105: 1660-8. PMID 20707784 DOI: 10.1111/j.1360-0443.2010.03020.x  1
2010 Lyons DM, Buckmaster PS, Lee AG, Wu C, Mitra R, Duffey LM, Buckmaster CL, Her S, Patel PD, Schatzberg AF. Stress coping stimulates hippocampal neurogenesis in adult monkeys. Proceedings of the National Academy of Sciences of the United States of America. 107: 14823-7. PMID 20675584 DOI: 10.1073/pnas.0914568107  1
2010 Bailey SR, Hammer SA, Bryson SW, Schatzberg AF, Killen JD. Using treatment process data to predict maintained smoking abstinence. American Journal of Health Behavior. 34: 801-10. PMID 20604703 DOI: 10.5555/ajhb.2010.34.6.801  1
2010 Sarginson JE, Lazzeroni LC, Ryan HS, Ershoff BD, Schatzberg AF, Murphy GM. ABCB1 (MDR1) polymorphisms and antidepressant response in geriatric depression. Pharmacogenetics and Genomics. 20: 467-75. PMID 20555295 DOI: 10.1097/FPC.0b013e32833b593a  1
2010 Zajecka J, Schatzberg A, Stahl S, Shah A, Caputo A, Post A. Efficacy and safety of agomelatine in the treatment of major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled trial. Journal of Clinical Psychopharmacology. 30: 135-44. PMID 20520286 DOI: 10.1097/JCP.0b013e3181d420a7  1
2010 Parker KJ, Kenna HA, Zeitzer JM, Keller J, Blasey CM, Amico JA, Schatzberg AF. Preliminary evidence that plasma oxytocin levels are elevated in major depression. Psychiatry Research. 178: 359-62. PMID 20494448 DOI: 10.1016/j.psychres.2009.09.017  1
2010 Reich J, Schatzberg A. Personality traits and medical outcome of cardiac illness. Journal of Psychiatric Research. 44: 1017-20. PMID 20451216 DOI: 10.1016/j.jpsychires.2010.03.016  1
2010 Rasgon NL, Kenna HA, Williams KE, Powers B, Wroolie T, Schatzberg AF. Rosiglitazone add-on in treatment of depressed patients with insulin resistance: a pilot study. Thescientificworldjournal. 10: 321-8. PMID 20191245 DOI: 10.1100/tsw.2010.32  1
2010 Lyons DM, Parker KJ, Schatzberg AF. Animal models of early life stress: Implications for understanding resilience. Developmental Psychobiology. 52: 402-10. PMID 20175105 DOI: 10.1002/dev.20429  1
2010 Ohayon MM, Schatzberg AF. Social phobia and depression: prevalence and comorbidity. Journal of Psychosomatic Research. 68: 235-43. PMID 20159208 DOI: 10.1016/j.jpsychores.2009.07.018  1
2010 Ohayon MM, Schatzberg AF. Chronic pain and major depressive disorder in the general population. Journal of Psychiatric Research. 44: 454-61. PMID 20149391 DOI: 10.1016/j.jpsychires.2009.10.013  1
2010 Etkin A, Prater KE, Hoeft F, Menon V, Schatzberg AF. Failure of anterior cingulate activation and connectivity with the amygdala during implicit regulation of emotional processing in generalized anxiety disorder. The American Journal of Psychiatry. 167: 545-54. PMID 20123913 DOI: 10.1176/appi.ajp.2009.09070931  1
2010 Buckley TM, Schatzberg AF. A pilot study of the phase angle between cortisol and melatonin in major depression - a potential biomarker? Journal of Psychiatric Research. 44: 69-74. PMID 20004915 DOI: 10.1016/j.jpsychires.2009.06.012  1
2010 Reimherr F, Amsterdam J, Dunner D, Adler L, Zhang S, Williams D, Marchant B, Michelson D, Nierenberg A, Schatzberg A, Feldman P. Genetic polymorphisms in the treatment of depression: speculations from an augmentation study using atomoxetine. Psychiatry Research. 175: 67-73. PMID 19969374 DOI: 10.1016/j.psychres.2009.01.005  1
2010 Sarginson JE, Lazzeroni LC, Ryan HS, Schatzberg AF, Murphy GM. FKBP5 polymorphisms and antidepressant response in geriatric depression. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 153: 554-60. PMID 19676097 DOI: 10.1002/ajmg.b.31019  1
2009 Etkin A, Prater KE, Schatzberg AF, Menon V, Greicius MD. Disrupted amygdalar subregion functional connectivity and evidence of a compensatory network in generalized anxiety disorder. Archives of General Psychiatry. 66: 1361-72. PMID 19996041 DOI: 10.1001/archgenpsychiatry.2009.104  1
2009 Lyons DM, Parker KJ, Katz M, Schatzberg AF. Developmental cascades linking stress inoculation, arousal regulation, and resilience. Frontiers in Behavioral Neuroscience. 3: 32. PMID 19826626 DOI: 10.3389/neuro.08.032.2009  1
2009 Schatzberg AF. Response to the presidential address. The American Journal of Psychiatry. 166: 1105-7. PMID 19797442 DOI: 10.1176/appi.ajp.2009.166.10.1105  1
2009 Martin MV, Rollins B, Sequeira PA, Mesén A, Byerley W, Stein R, Moon EA, Akil H, Jones EG, Watson SJ, Barchas J, DeLisi LE, Myers RM, Schatzberg A, Bunney WE, et al. Exon expression in lymphoblastoid cell lines from subjects with schizophrenia before and after glucose deprivation. Bmc Medical Genomics. 2: 62. PMID 19772658 DOI: 10.1186/1755-8794-2-62  1
2009 Kupfer DJ, Schatzberg AF, Grochocinski VJ, Dunn LO, Kelley KA, O'Hara RM. The Career Development Institute for Psychiatry: an innovative, longitudinal program for physician-scientists. Academic Psychiatry : the Journal of the American Association of Directors of Psychiatric Residency Training and the Association For Academic Psychiatry. 33: 313-8. PMID 19690113 DOI: 10.1176/appi.ap.33.4.313  1
2009 Bailey SR, Harrison CT, Jeffery CJ, Ammerman S, Bryson SW, Killen DT, Robinson TN, Schatzberg AF, Killen JD. Withdrawal symptoms over time among adolescents in a smoking cessation intervention: do symptoms vary by level of nicotine dependence? Addictive Behaviors. 34: 1017-22. PMID 19647373 DOI: 10.1016/j.addbeh.2009.06.014  1
2009 Amsterdam JD, Williams D, Michelson D, Adler LA, Dunner DL, Nierenberg AA, Reimherr FW, Schatzberg AF. Tachyphylaxis after repeated antidepressant drug exposure in patients with recurrent major depressive disorder. Neuropsychobiology. 59: 227-33. PMID 19571597 DOI: 10.1159/000226611  1
2009 Katz M, Liu C, Schaer M, Parker KJ, Ottet MC, Epps A, Buckmaster CL, Bammer R, Moseley ME, Schatzberg AF, Eliez S, Lyons DM. Prefrontal plasticity and stress inoculation-induced resilience. Developmental Neuroscience. 31: 293-9. PMID 19546566 DOI: 10.1159/000216540  1
2009 Scott LJ, Muglia P, Kong XQ, Guan W, Flickinger M, Upmanyu R, Tozzi F, Li JZ, Burmeister M, Absher D, Thompson RC, Francks C, Meng F, Antoniades A, Southwick AM, ... Schatzberg AF, et al. Genome-wide association and meta-analysis of bipolar disorder in individuals of European ancestry. Proceedings of the National Academy of Sciences of the United States of America. 106: 7501-6. PMID 19416921 DOI: 10.1073/pnas.0813386106  1
2009 Reynolds CF, Lewis DA, Detre T, Schatzberg AF, Kupfer DJ. The future of psychiatry as clinical neuroscience. Academic Medicine : Journal of the Association of American Medical Colleges. 84: 446-50. PMID 19318776 DOI: 10.1097/ACM.0b013e31819a8052  1
2009 Schatzberg AF. The silver lining of recent effectiveness trials. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 8: 30-2. PMID 19293954  1
2009 Rollins B, Martin MV, Sequeira PA, Moon EA, Morgan LZ, Watson SJ, Schatzberg A, Akil H, Myers RM, Jones EG, Wallace DC, Bunney WE, Vawter MP. Mitochondrial variants in schizophrenia, bipolar disorder, and major depressive disorder. Plos One. 4: e4913. PMID 19290059 DOI: 10.1371/journal.pone.0004913  1
2009 Reaven GM, Lieberman JA, Sethuraman G, Kraemer H, Davis JM, Blasey C, Tsuang MT, Schatzberg AF. In search of moderators and mediators of hyperglycemia with atypical antipsychotic treatment. Journal of Psychiatric Research. 43: 997-1002. PMID 19268968 DOI: 10.1016/j.jpsychires.2009.01.010  1
2009 Gomez RG, Posener JA, Keller J, DeBattista C, Solvason B, Schatzberg AF. Effects of major depression diagnosis and cortisol levels on indices of neurocognitive function. Psychoneuroendocrinology. 34: 1012-8. PMID 19261389 DOI: 10.1016/j.psyneuen.2009.01.017  1
2009 Perahia DG, Quail D, Desaiah D, Montejo AL, Schatzberg AF. Switching to duloxetine in selective serotonin reuptake inhibitor non- and partial-responders: effects on painful physical symptoms of depression. Journal of Psychiatric Research. 43: 512-8. PMID 18707693 DOI: 10.1016/j.jpsychires.2008.07.001  1
2009 Goldman HH, Adler DA, Druss B, Harding RK, Marder SR, Norquist GS, Ruiz P, Stein BD, Sullivan G, Swartz MS, Valenstein M, Wilson RC, Zima BT, Talbott JA, Geller JL, ... ... Schatzberg A, et al. Taking issue Psychiatric Services. 60: 575. DOI: 10.1176/appi.ps.60.5.575  1
2009 Schatzberg AF, Norris KT. Psychiatric Disorders Clinical and Translational Science. 461-475. DOI: 10.1016/B978-0-12-373639-0.00031-5  1
2009 Schatzberg AF. The silver lining of recent effectiveness trials | Dobre strony najnowszych badań efektywności Postepy Psychiatrii I Neurologii. 18: 120-121.  1
2009 Schatzberg AF, Scully JH, Kupfer DJ, Regier DA. Setting the record straight: A response to Dr Frances' commentary on DSM-V Psychiatric Times. 26: 1+9-10.  1
2008 Schatzberg AF. Achieving remission and favorable outcomes in patients with depression/anxiety and substance use disorders. Cns Spectrums. 13: 10-2. PMID 19317018  1
2008 Trivedi MH, Kocsis JH, Thase ME, Morris DW, Wisniewski SR, Leon AC, Gelenberg AJ, Klein DN, Niederehe G, Schatzberg AF, Ninan PT, Keller MB. REVAMP - Research Evaluating the Value of Augmenting Medication with Psychotherapy: rationale and design. Psychopharmacology Bulletin. 41: 5-33. PMID 19015627  1
2008 Killen JD, Fortmann SP, Schatzberg AF, Arredondo C, Murphy G, Hayward C, Celio M, Cromp D, Fong D, Pandurangi M. Extended cognitive behavior therapy for cigarette smoking cessation. Addiction (Abingdon, England). 103: 1381-90. PMID 18855829 DOI: 10.1111/j.1360-0443.2008.02273.x  1
2008 Buckley T, Duggal V, Schatzberg AF. The acute and post-discontinuation effects of a glucocorticoid receptor (GR) antagonist probe on sleep and the HPA axis in chronic insomnia: a pilot study. Journal of Clinical Sleep Medicine : Jcsm : Official Publication of the American Academy of Sleep Medicine. 4: 235-41. PMID 18595436  1
2008 Keller J, Shen L, Gomez RG, Garrett A, Solvason HB, Reiss A, Schatzberg AF. Hippocampal and amygdalar volumes in psychotic and nonpsychotic unipolar depression. The American Journal of Psychiatry. 165: 872-80. PMID 18450931 DOI: 10.1176/appi.ajp.2008.07081257  1
2008 Shao L, Martin MV, Watson SJ, Schatzberg A, Akil H, Myers RM, Jones EG, Bunney WE, Vawter MP. Mitochondrial involvement in psychiatric disorders. Annals of Medicine. 40: 281-95. PMID 18428021 DOI: 10.1080/07853890801923753  1
2008 Schatzberg AF, Weiss RD, Brady KT, Culpepper L. Bridging the clinical gap: managing patients with co-occurring mood, anxiety, and alcohol use disorders. Introduction. Cns Spectrums. 13: 3. PMID 18408653  1
2008 Sequeira A, Meng F, Rollins B, Myers RM, Jones EG, Watson SJ, Akil H, Schatzberg AF, Barchas J, Bunney WE, Vawter MP. Coding SNPs included in exon arrays for the study of psychiatric disorders. Molecular Psychiatry. 13: 363-5. PMID 18347597 DOI: 10.1038/sj.mp.4002123  1
2008 Schatzberg AF, Lindley S. Glucocorticoid antagonists in neuropsychiatric [corrected] disorders. European Journal of Pharmacology. 583: 358-64. PMID 18339372 DOI: 10.1016/j.ejphar.2008.01.001  1
2008 Schatzberg AF, Lindley S. Corrigendum to: Glucocorticoid antagonists in neuropsychiatric disorders [European Journal of Pharmacology 583 (2008) 358-364] (DOI:10.1016/j.ejphar.2008.01.001) European Journal of Pharmacology. 592: 168. DOI: 10.1016/j.ejphar.2008.06.058  1
2008 Solvason HB, Schatzberg A. Current Prognosis of Depression Biology of Depression: From Novel Insights to Therapeutic Strategies. 223-251. DOI: 10.1002/9783527619672.ch8  1
2008 Duman R, Polan HJ, Schatzberg A, Kandel ER. Neurobiologic Foundations of Mood Disorders Psychiatry: Third Edition. 1: 339-353. DOI: 10.1002/9780470515167.ch21  1
2007 Sartorius N, Baghai TC, Baldwin DS, Barrett B, Brand U, Fleischhacker W, Goodwin G, Grunze H, Knapp M, Leonard BE, Lieberman J, Nakane Y, Pinder RM, Schatzberg AF, Svestka J, et al. Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidence. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 10: S1-207. PMID 18096106 DOI: 10.1017/S1461145707008255  1
2007 Montgomery SA, Baldwin DS, Blier P, Fineberg NA, Kasper S, Lader M, Lam RW, Lépine JP, Möller HJ, Nutt DJ, Rouillon F, Schatzberg AF, Thase ME. Which antidepressants have demonstrated superior efficacy? A review of the evidence. International Clinical Psychopharmacology. 22: 323-9. PMID 17917550 DOI: 10.1097/YIC.0b013e3282eff7e0  1
2007 Karssen AM, Her S, Li JZ, Patel PD, Meng F, Bunney WE, Jones EG, Watson SJ, Akil H, Myers RM, Schatzberg AF, Lyons DM. Stress-induced changes in primate prefrontal profiles of gene expression. Molecular Psychiatry. 12: 1089-102. PMID 17893703 DOI: 10.1038/sj.mp.4002095  1
2007 Keller MB, Trivedi MH, Thase ME, Shelton RC, Kornstein SG, Nemeroff CB, Friedman ES, Gelenberg AJ, Kocsis JH, Dunner DL, Hirschfeld RM, Rothschild AJ, Ferguson JM, Schatzberg AF, Zajecka JM, et al. The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases. The Journal of Clinical Psychiatry. 68: 1246-56. PMID 17854250  1
2007 Keller MB, Trivedi MH, Thase ME, Shelton RC, Kornstein SG, Nemeroff CB, Friedman ES, Gelenberg AJ, Kocsis JH, Dunner DL, Dunlop BW, Hirschfeld RM, Rothschild AJ, Ferguson JM, Schatzberg AF, et al. The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) study: outcomes from the acute and continuation phases. Biological Psychiatry. 62: 1371-9. PMID 17825800 DOI: 10.1016/j.biopsych.2007.04.040  1
2007 Kocsis JH, Thase ME, Trivedi MH, Shelton RC, Kornstein SG, Nemeroff CB, Friedman ES, Gelenberg AJ, Dunner DL, Hirschfeld RM, Rothschild AJ, Ferguson JM, Schatzberg AF, Zajecka JM, Pedersen RD, et al. Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT Study. The Journal of Clinical Psychiatry. 68: 1014-23. PMID 17685736  1
2007 Buckley TM, Mullen BC, Schatzberg AF. The acute effects of a mineralocorticoid receptor (MR) agonist on nocturnal hypothalamic-adrenal-pituitary (HPA) axis activity in healthy controls. Psychoneuroendocrinology. 32: 859-64. PMID 17666187 DOI: 10.1016/j.psyneuen.2007.05.016  1
2007 Schatzberg AF. Safety and tolerability of antidepressants: weighing the impact on treatment decisions. The Journal of Clinical Psychiatry. 68: 26-34. PMID 17640155  1
2007 Parker KJ, Rainwater KL, Buckmaster CL, Schatzberg AF, Lindley SE, Lyons DM. Early life stress and novelty seeking behavior in adolescent monkeys. Psychoneuroendocrinology. 32: 785-92. PMID 17604913 DOI: 10.1016/j.psyneuen.2007.05.008  1
2007 Lyons DM, Parker KJ, Zeitzer JM, Buckmaster CL, Schatzberg AF. Preliminary evidence that hippocampal volumes in monkeys predict stress levels of adrenocorticotropic hormone. Biological Psychiatry. 62: 1171-4. PMID 17573043 DOI: 10.1016/j.biopsych.2007.03.012  1
2007 Keller J, Schatzberg AF, Maj M. Current issues in the classification of psychotic major depression. Schizophrenia Bulletin. 33: 877-85. PMID 17548842 DOI: 10.1093/schbul/sbm065  1
2007 Michelson D, Adler LA, Amsterdam JD, Dunner DL, Nierenberg AA, Reimherr FW, Schatzberg AF, Kelsey DK, Williams DW. Addition of atomoxetine for depression incompletely responsive to sertraline: a randomized, double-blind, placebo-controlled study. The Journal of Clinical Psychiatry. 68: 582-7. PMID 17474814  1
2007 Nemeroff CB, Kalali A, Keller MB, Charney DS, Lenderts SE, Cascade EF, Stephenson H, Schatzberg AF. Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States. Archives of General Psychiatry. 64: 466-72. PMID 17404123 DOI: 10.1001/archpsyc.64.4.466  1
2007 Ohayon MM, Schatzberg AF. Biomarkers and classifications. Journal of Psychiatric Research. 41: 623-4. PMID 17403443 DOI: 10.1016/j.jpsychires.2007.03.003  1
2007 O'Hara R, Schröder CM, Mahadevan R, Schatzberg AF, Lindley S, Fox S, Weiner M, Kraemer HC, Noda A, Lin X, Gray HL, Hallmayer JF. Serotonin transporter polymorphism, memory and hippocampal volume in the elderly: association and interaction with cortisol. Molecular Psychiatry. 12: 544-55. PMID 17353910 DOI: 10.1038/sj.mp.4001978  1
2007 Seeley WW, Menon V, Schatzberg AF, Keller J, Glover GH, Kenna H, Reiss AL, Greicius MD. Dissociable intrinsic connectivity networks for salience processing and executive control. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 2349-56. PMID 17329432 DOI: 10.1523/JNEUROSCI.5587-06.2007  1
2007 Greicius MD, Flores BH, Menon V, Glover GH, Solvason HB, Kenna H, Reiss AL, Schatzberg AF. Resting-state functional connectivity in major depression: abnormally increased contributions from subgenual cingulate cortex and thalamus. Biological Psychiatry. 62: 429-37. PMID 17210143 DOI: 10.1016/j.biopsych.2006.09.020  1
2006 Schatzberg AF. New paradigm for treating recurrent depression: from symptom control to managing enduring vulnerabilities. Cns Spectrums. 11: 22-7. PMID 17146415  1
2006 Mitra R, Sundlass K, Parker KJ, Schatzberg AF, Lyons DM. Social stress-related behavior affects hippocampal cell proliferation in mice. Physiology & Behavior. 89: 123-7. PMID 16837015 DOI: 10.1016/j.physbeh.2006.05.047  1
2006 Rush AJ, Kraemer HC, Sackeim HA, Fava M, Trivedi MH, Frank E, Ninan PT, Thase ME, Gelenberg AJ, Kupfer DJ, Regier DA, Rosenbaum JF, Ray O, Schatzberg AF. Report by the ACNP Task Force on response and remission in major depressive disorder. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 1841-53. PMID 16794566 DOI: 10.1038/sj.npp.1301131  1
2006 Schatzberg AF, Blier P, Delgado PL, Fava M, Haddad PM, Shelton RC. Antidepressant discontinuation syndrome: consensus panel recommendations for clinical management and additional research. The Journal of Clinical Psychiatry. 67: 27-30. PMID 16683860  1
2006 Killen JD, Fortmann SP, Murphy GM, Hayward C, Arredondo C, Cromp D, Celio M, Abe L, Wang Y, Schatzberg AF. Extended treatment with bupropion SR for cigarette smoking cessation. Journal of Consulting and Clinical Psychology. 74: 286-94. PMID 16649873 DOI: 10.1037/0022-006X.74.2.286  1
2006 Schatzberg A, Roose S. A double-blind, placebo-controlled study of venlafaxine and fluoxetine in geriatric outpatients with major depression. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 14: 361-70. PMID 16582045 DOI: 10.1097/01.JGP.0000194645.70869.3b  1
2006 Gomez RG, Fleming SH, Keller J, Flores B, Kenna H, DeBattista C, Solvason B, Schatzberg AF. The neuropsychological profile of psychotic major depression and its relation to cortisol. Biological Psychiatry. 60: 472-8. PMID 16483550 DOI: 10.1016/j.biopsych.2005.11.010  1
2006 Parker KJ, Buckmaster CL, Sundlass K, Schatzberg AF, Lyons DM. Maternal mediation, stress inoculation, and the development of neuroendocrine stress resistance in primates. Proceedings of the National Academy of Sciences of the United States of America. 103: 3000-5. PMID 16473950 DOI: 10.1073/pnas.0506571103  1
2006 Karssen AM, Li JZ, Her S, Patel PD, Meng F, Evans SJ, Vawter MP, Tomita H, Choudary PV, Bunney WE, Jones EG, Watson SJ, Akil H, Myers RM, Schatzberg AF, et al. Application of microarray technology in primate behavioral neuroscience research. Methods (San Diego, Calif.). 38: 227-34. PMID 16469505 DOI: 10.1016/j.ymeth.2005.09.017  1
2006 Keller J, Flores B, Gomez RG, Solvason HB, Kenna H, Williams GH, Schatzberg AF. Cortisol circadian rhythm alterations in psychotic major depression. Biological Psychiatry. 60: 275-81. PMID 16458262 DOI: 10.1016/j.biopsych.2005.10.014  1
2006 Keller J, Gomez RG, Kenna HA, Poesner J, DeBattista C, Flores B, Schatzberg AF. Detecting psychotic major depression using psychiatric rating scales. Journal of Psychiatric Research. 40: 22-9. PMID 16165160 DOI: 10.1016/j.jpsychires.2005.07.003  1
2006 Flores BH, Kenna H, Keller J, Solvason HB, Schatzberg AF. Clinical and biological effects of mifepristone treatment for psychotic depression. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 628-36. PMID 16160710 DOI: 10.1038/sj.npp.1300884  1
2006 Keller J, Schatzberg AF. Reply: Clinical and biological effects of mifepristone treatment for psychotic treatment [2] Neuropsychopharmacology. 31: 2795-2797. DOI: 10.1038/sj.npp.1301171  1
2006 Ohayon MM, Schatzberg AF. Fine-tuning our diagnosis and treatment of depression Journal of Psychiatric Research. 40: 281-282. DOI: 10.1016/j.jpsychires.2006.04.005  1
2006 Schatzberg AF. Foreword Biological Psychiatry. 59: viii. DOI: 10.1016/j.biopsych.2006.02.005  1
2006 DeBattista C, Schatzberg AF. Psychotropic dosing and monitoring guidelines Primary Psychiatry. 13: 61-81.  1
2005 Belanoff JK, Sund B, Koopman C, Blasey C, Flamm J, Schatzberg AF, Spiegel D. A randomized trial of the efficacy of group therapy in changing viral load and CD4 counts in individuals living with HIV infection. International Journal of Psychiatry in Medicine. 35: 349-62. PMID 16673835 DOI: 10.2190/4N6W-BUYY-CFNE-67XH  1
2005 Nemeroff CB, Lieberman JA, Weiden PJ, Harvey PD, Newcomer JW, Schatzberg AF, Kilts CD, Daniel DG. From clinical research to clinical practice: a 4-year review of ziprasidone. Cns Spectrums. 10: 1-20. PMID 16381088  1
2005 Debattista C, Solomon A, Arnow B, Kendrick E, Tilston J, Schatzberg AF. The efficacy of divalproex sodium in the treatment of agitation associated with major depression. Journal of Clinical Psychopharmacology. 25: 476-9. PMID 16160625 DOI: 10.1097/01.jcp.0000177552.21338.b0  1
2005 O'Hara R, Schröder CM, Kraemer HC, Kryla N, Cao C, Miller E, Schatzberg AF, Yesavage JA, Murphy GM. Nocturnal sleep apnea/hypopnea is associated with lower memory performance in APOE epsilon4 carriers. Neurology. 65: 642-4. PMID 16116137 DOI: 10.1212/01.wnl.0000173055.75950.bf  1
2005 Roose SP, Schatzberg AF. The efficacy of antidepressants in the treatment of late-life depression. Journal of Clinical Psychopharmacology. 25: S1-7. PMID 16027554 DOI: 10.1097/01.jcp.0000162807.84570.6b  1
2005 Parker KJ, Buckmaster CL, Schatzberg AF, Lyons DM. Intranasal oxytocin administration attenuates the ACTH stress response in monkeys. Psychoneuroendocrinology. 30: 924-9. PMID 15946803 DOI: 10.1016/j.psyneuen.2005.04.002  1
2005 Lindley SE, She X, Schatzberg AF. Monoamine oxidase and catechol-o-methyltransferase enzyme activity and gene expression in response to sustained glucocorticoids. Psychoneuroendocrinology. 30: 785-90. PMID 15919584 DOI: 10.1016/j.psyneuen.2005.03.007  1
2005 Buckley TM, Schatzberg AF. Aging and the role of the HPA axis and rhythm in sleep and memory-consolidation. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 13: 344-52. PMID 15879582 DOI: 10.1176/appi.ajgp.13.5.344  1
2005 Schatzberg AF, Rush AJ, Arnow BA, Banks PL, Blalock JA, Borian FE, Howland R, Klein DN, Kocsis JH, Kornstein SG, Manber R, Markowitz JC, Miller I, Ninan PT, Rothbaum BO, et al. Chronic depression: medication (nefazodone) or psychotherapy (CBASP) is effective when the other is not. Archives of General Psychiatry. 62: 513-20. PMID 15867104 DOI: 10.1001/archpsyc.62.5.513  1
2005 Her S, Patel PD, Schatzberg AF, Lyons DM. Mutations in squirrel monkey glucocorticoid receptor impair nuclear translocation. The Journal of Steroid Biochemistry and Molecular Biology. 94: 319-26. PMID 15857751 DOI: 10.1016/j.jsbmb.2004.11.010  1
2005 Parker KJ, Buckmaster CL, Justus KR, Schatzberg AF, Lyons DM. Mild early life stress enhances prefrontal-dependent response inhibition in monkeys. Biological Psychiatry. 57: 848-55. PMID 15820705 DOI: 10.1016/j.biopsych.2004.12.024  1
2005 Buckley TM, Schatzberg AF. On the interactions of the hypothalamic-pituitary-adrenal (HPA) axis and sleep: normal HPA axis activity and circadian rhythm, exemplary sleep disorders. The Journal of Clinical Endocrinology and Metabolism. 90: 3106-14. PMID 15728214 DOI: 10.1210/jc.2004-1056  1
2005 Brannan SK, Mallinckrodt CH, Brown EB, Wohlreich MM, Watkin JG, Schatzberg AF. Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder. Journal of Psychiatric Research. 39: 43-53. PMID 15504423 DOI: 10.1016/j.jpsychires.2004.04.011  1
2004 Schatzberg AF. Employing pharmacologic treatment of bipolar disorder to greatest effect. The Journal of Clinical Psychiatry. 65: 15-20. PMID 15554791  1
2004 Murphy GM, Hollander SB, Rodrigues HE, Kremer C, Schatzberg AF. Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression. Archives of General Psychiatry. 61: 1163-9. PMID 15520364 DOI: 10.1001/archpsyc.61.11.1163  1
2004 Killen JD, Robinson TN, Ammerman S, Hayward C, Rogers J, Samuels D, Schatzberg AF. Major depression among adolescent smokers undergoing treatment for nicotine dependence. Addictive Behaviors. 29: 1517-26. PMID 15451121 DOI: 10.1016/j.addbeh.2004.02.029  1
2004 Parker KJ, Buckmaster CL, Schatzberg AF, Lyons DM. Prospective investigation of stress inoculation in young monkeys. Archives of General Psychiatry. 61: 933-41. PMID 15351772 DOI: 10.1001/archpsyc.61.9.933  1
2004 Killen JD, Robinson TN, Ammerman S, Hayward C, Rogers J, Stone C, Samuels D, Levin SK, Green S, Schatzberg AF. Randomized clinical trial of the efficacy of bupropion combined with nicotine patch in the treatment of adolescent smokers. Journal of Consulting and Clinical Psychology. 72: 729-35. PMID 15301658 DOI: 10.1037/0022-006X.72.4.729  1
2004 Rothschild AJ, Williamson DJ, Tohen MF, Schatzberg A, Andersen SW, Van Campen LE, Sanger TM, Tollefson GD. A double-blind, randomized study of olanzapine and olanzapine/fluoxetine combination for major depression with psychotic features. Journal of Clinical Psychopharmacology. 24: 365-73. PMID 15232326 DOI: 10.1097/01.jcp.0000130557.08996.7a  1
2004 Young EA, Altemus M, Lopez JF, Kocsis JH, Schatzberg AF, DeBattista C, Zubieta JK. HPA axis activation in major depression and response to fluoxetine: a pilot study. Psychoneuroendocrinology. 29: 1198-204. PMID 15219644 DOI: 10.1016/j.psyneuen.2004.02.002  1
2004 Posener JA, Charles DeBattista, Veldhuis JD, Province MA, Williams GH, Schatzberg AF. Process irregularity of cortisol and adrenocorticotropin secretion in men with major depressive disorder. Psychoneuroendocrinology. 29: 1129-37. PMID 15219636 DOI: 10.1016/j.psyneuen.2004.01.004  1
2004 Lyons DM, Yang C, Eliez S, Reiss AL, Schatzberg AF. Cognitive correlates of white matter growth and stress hormones in female squirrel monkey adults. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 3655-62. PMID 15071114 DOI: 10.1523/JNEUROSCI.0324-04.2004  1
2004 Schatzberg AF. Pharmacologic treatments of major depression: are two mechanisms really better than one? The Journal of Clinical Psychiatry. 65: 3-4. PMID 15046535  1
2004 Fleming SK, Blasey C, Schatzberg AF. Neuropsychological correlates of psychotic features in major depressive disorders: a review and meta-analysis. Journal of Psychiatric Research. 38: 27-35. PMID 14690768 DOI: 10.1016/S0022-3956(03)00100-6  1
2004 Schatzberg AF. Non-schizophrenic psychoses: common and distinguishing features. Journal of Psychiatric Research. 38: 1-2. PMID 14690765 DOI: 10.1016/S0022-3956(03)00093-1  1
2004 Härtter S, Murphy GM, Schatzberg AF. Genetics in pharmacokinetics? [4] (multiple letters) American Journal of Psychiatry. 161: 1308-1309.  1
2003 Schatzberg AF. Introduction: treating depression and anxiety to remission. The Journal of Clinical Psychiatry. 64: 3-4. PMID 14658983  1
2003 Nemeroff CB, Heim CM, Thase ME, Klein DN, Rush AJ, Schatzberg AF, Ninan PT, McCullough JP, Weiss PM, Dunner DL, Rothbaum BO, Kornstein S, Keitner G, Keller MB. Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma. Proceedings of the National Academy of Sciences of the United States of America. 100: 14293-6. PMID 14615578 DOI: 10.1073/pnas.2336126100  1
2003 Schatzberg AF. Efficacy and tolerability of duloxetine, a novel dual reuptake inhibitor, in the treatment of major depressive disorder. The Journal of Clinical Psychiatry. 64: 30-7. PMID 14552654  1
2003 Boyett-Anderson JM, Lyons DM, Reiss AL, Schatzberg AF, Menon V. Functional brain imaging of olfactory processing in monkeys. Neuroimage. 20: 257-64. PMID 14527586 DOI: 10.1016/S1053-8119(03)00288-X  1
2003 Murphy GM, Kremer C, Rodrigues HE, Schatzberg AF. Pharmacogenetics of antidepressant medication intolerance. The American Journal of Psychiatry. 160: 1830-5. PMID 14514498 DOI: 10.1176/appi.ajp.160.10.1830  1
2003 Murphy GM, Kremer C, Rodrigues H, Schatzberg AF. The apolipoprotein E epsilon4 allele and antidepressant efficacy in cognitively intact elderly depressed patients. Biological Psychiatry. 54: 665-73. PMID 14512205 DOI: 10.1016/S0006-3223(03)00174-4  1
2003 Lyons DM, Schatzberg AF. Early maternal availability and prefrontal correlates of reward-related memory. Neurobiology of Learning and Memory. 80: 97-104. PMID 12932424 DOI: 10.1016/S1074-7427(03)00044-3  1
2003 Mallick R, Chen J, Entsuah AR, Schatzberg AF. Depression-free days as a summary measure of the temporal pattern of response and remission in the treatment of major depression: a comparison of venlafaxine, selective serotonin reuptake inhibitors, and placebo. The Journal of Clinical Psychiatry. 64: 321-30. PMID 12716275  1
2003 Killen JD, Fortmann SP, Schatzberg A, Hayward C, Varady A. Onset of major depression during treatment for nicotine dependence. Addictive Behaviors. 28: 461-70. PMID 12628619 DOI: 10.1016/S0306-4603(01)00266-0  1
2003 Schatzberg AF. New approaches to managing psychotic depression. The Journal of Clinical Psychiatry. 64: 19-23. PMID 12625801  1
2003 Greicius MD, Krasnow B, Boyett-Anderson JM, Eliez S, Schatzberg AF, Reiss AL, Menon V. Regional analysis of hippocampal activation during memory encoding and retrieval: fMRI study. Hippocampus. 13: 164-74. PMID 12625466 DOI: 10.1002/hipo.10064  1
2003 Parker KJ, Schatzberg AF, Lyons DM. Neuroendocrine aspects of hypercortisolism in major depression. Hormones and Behavior. 43: 60-6. PMID 12614635 DOI: 10.1016/S0018-506X(02)00016-8  1
2003 DeBattista C, Solvason HB, Poirier J, Kendrick E, Schatzberg AF. A prospective trial of bupropion SR augmentation of partial and non-responders to serotonergic antidepressants. Journal of Clinical Psychopharmacology. 23: 27-30. PMID 12544372 DOI: 10.1097/00004714-200302000-00005  1
2003 Ohayon MM, Schatzberg AF. Using chronic pain to predict depressive morbidity in the general population. Archives of General Psychiatry. 60: 39-47. PMID 12511171  1
2003 Schatzberg AF. Introduction: Recent Developments in Achieving Depression Remission Journal of Clinical Psychiatry. 64: 4.  1
2003 DeBattista C, Schatzberg AF, Norris KT. 2003 Psychotropic Dosing and Monitoring Guidelines Primary Psychiatry. 10: 80-84+87-96.  1
2002 Nemeroff CB, Schatzberg AF, Goldstein DJ, Detke MJ, Mallinckrodt C, Lu Y, Tran PV. Duloxetine for the treatment of major depressive disorder. Psychopharmacology Bulletin. 36: 106-32. PMID 12858150  1
2002 Lindley SE, Bengoechea TG, Wong DL, Schatzberg AF. Mesotelencephalic dopamine neurochemical responses to glucocorticoid administration and adrenalectomy in Fischer 344 and Lewis rats. Brain Research. 958: 414-22. PMID 12470878 DOI: 10.1016/S0006-8993(02)03719-8  1
2002 Ohayon MM, Schatzberg AF. Prevalence of depressive episodes with psychotic features in the general population. The American Journal of Psychiatry. 159: 1855-61. PMID 12411219 DOI: 10.1176/appi.ajp.159.11.1855  1
2002 Schatzberg AF. Brain imaging in affective disorders: more questions about causes versus effects. The American Journal of Psychiatry. 159: 1807-8. PMID 12411210 DOI: 10.1176/appi.ajp.159.11.1807  1
2002 Lyons DM, Afarian H, Schatzberg AF, Sawyer-Glover A, Moseley ME. Experience-dependent asymmetric variation in primate prefrontal morphology. Behavioural Brain Research. 136: 51-9. PMID 12385789 DOI: 10.1016/S0166-4328(02)00100-6  1
2002 Tamminga CA, Nemeroff CB, Blakely RD, Brady L, Carter CS, Davis KL, Dingledine R, Gorman JM, Grigoriadis DE, Henderson DC, B Innis RB, Killen J, Laughren TP, McDonald WM, M Murphy GM, ... ... Schatzberg AF, et al. Developing novel treatments for mood disorders: accelerating discovery. Biological Psychiatry. 52: 589-609. PMID 12361670 DOI: 10.1016/S0006-3223(02)01470-1  1
2002 Belanoff JK, Rothschild AJ, Cassidy F, DeBattista C, Baulieu EE, Schold C, Schatzberg AF. An open label trial of C-1073 (mifepristone) for psychotic major depression. Biological Psychiatry. 52: 386-92. PMID 12242054 DOI: 10.1016/S0006-3223(02)01432-4  1
2002 Schatzberg AF, Kremer C, Rodrigues HE, Murphy GM. Double-blind, randomized comparison of mirtazapine and paroxetine in elderly depressed patients. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 10: 541-50. PMID 12213688  0.32
2002 Belanoff JK, Jurik J, Schatzberg LD, DeBattista C, Schatzberg AF. Slowing the progression of cognitive decline in Alzheimer's disease using mifepristone. Journal of Molecular Neuroscience : Mn. 19: 201-6. PMID 12212781 DOI: 10.1007/s12031-002-0033-3  1
2002 Kocsis JH, Schatzberg A, Rush AJ, Klein DN, Howland R, Gniwesch L, Davis SM, Harrison W. Psychosocial outcomes following long-term, double-blind treatment of chronic depression with sertraline vs placebo. Archives of General Psychiatry. 59: 723-8. PMID 12150648  1
2002 Kupfer DJ, Hyman SE, Schatzberg AF, Pincus HA, Reynolds CF. Recruiting and retaining future generations of physician scientists in mental health. Archives of General Psychiatry. 59: 657-60. PMID 12090819  1
2002 Menon V, Boyett-Anderson JM, Schatzberg AF, Reiss AL. Relating semantic and episodic memory systems. Brain Research. Cognitive Brain Research. 13: 261-5. PMID 11958970  0.68
2002 Charney DS, Nemeroff CB, Lewis L, Laden SK, Gorman JM, Laska EM, Borenstein M, Bowden CL, Caplan A, Emslie GJ, Evans DL, Geller B, Grabowski LE, Herson J, Kalin NH, ... ... Schatzberg AF, et al. National Depressive and Manic-Depressive Association consensus statement on the use of placebo in clinical trials of mood disorders. Archives of General Psychiatry. 59: 262-70. PMID 11879164  1
2002 Hirschfeld RM, Dunner DL, Keitner G, Klein DN, Koran LM, Kornstein SG, Markowitz JC, Miller I, Nemeroff CB, Ninan PT, Rush AJ, Schatzberg AF, Thase ME, Trivedi MH, Borian FE, et al. Does psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy, and their combination. Biological Psychiatry. 51: 123-33. PMID 11822991  0.32
2002 Sommer BR, Schatzberg AF. Ginkgo biloba and related compounds in Alzheimer's disease Psychiatric Annals. 32: 13-18.  1
2002 DeBattista C, Rothschild AJ, Schatzberg AF. A dynamic algorithm for the treatment of psychotic major depression Psychiatric Annals. 32: 681-691.  1
2001 Lyons DM, Yang C, Sawyer-Glover AM, Moseley ME, Schatzberg AF. Early life stress and inherited variation in monkey hippocampal volumes. Archives of General Psychiatry. 58: 1145-51. PMID 11735843  1
2001 Posener JA, DeBattista C, Williams GH, Schatzberg AF. Cortisol feedback during the HPA quiescent period in patients with major depression. The American Journal of Psychiatry. 158: 2083-5. PMID 11729034  0.52
2001 Claassen JD, Pascoe N, Schatzberg AF, Murphy GM. Rapid detection of the C-1496G polymorphism in the CYP2D6 *2 allele. Clinical Chemistry. 47: 2153-5. PMID 11719482  0.32
2001 Chu JW, Matthias DF, Belanoff J, Schatzberg A, Hoffman AR, Feldman D. Successful long-term treatment of refractory Cushing's disease with high-dose mifepristone (RU 486). The Journal of Clinical Endocrinology and Metabolism. 86: 3568-73. PMID 11502780 DOI: 10.1210/jcem.86.8.7740  1
2001 Koran LM, Gelenberg AJ, Kornstein SG, Howland RH, Friedman RA, DeBattista C, Klein D, Kocsis JH, Schatzberg AF, Thase ME, Rush AJ, Hirschfeld RM, LaVange LM, Keller MB. Sertraline versus imipramine to prevent relapse in chronic depression. Journal of Affective Disorders. 65: 27-36. PMID 11426506 DOI: 10.1016/S0165-0327(00)00272-X  1
2000 Kornstein SG, Schatzberg AF, Thase ME, Yonkers KA, McCullough JP, Keitner GI, Gelenberg AJ, Ryan CE, Hess AL, Harrison W, Davis SM, Keller MB. Gender differences in chronic major and double depression. Journal of Affective Disorders. 60: 1-11. PMID 10940442 DOI: 10.1016/S0165-0327(99)00158-5  1
2000 Posener JA, DeBattista C, Williams GH, Chmura Kraemer H, Kalehzan BM, Schatzberg AF. 24-Hour monitoring of cortisol and corticotropin secretion in psychotic and nonpsychotic major depression. Archives of General Psychiatry. 57: 755-60. PMID 10920463  0.52
2000 DeBattista C, Posener JA, Kalehzan BM, Schatzberg AF. Acute antidepressant effects of intravenous hydrocortisone and CRH in depressed patients: a double-blind, placebo-controlled study. The American Journal of Psychiatry. 157: 1334-7. PMID 10910802  0.52
2000 Schatzberg AF, Posener JA, DeBattista C, Kalehzan BM, Rothschild AJ, Shear PK. Neuropsychological deficits in psychotic versus nonpsychotic major depression and no mental illness. The American Journal of Psychiatry. 157: 1095-100. PMID 10873917 DOI: 10.1176/appi.ajp.157.7.1095  1
2000 Tolwani RJ, Waggie KS, Green SL, Tolwani AJ, Lyons DM, Schatzberg AF. Dilative cardiomyopathy leading to congestive heart failure in a male squirrel monkey (Saimiri sciureus). Journal of Medical Primatology. 29: 42-5. PMID 10870674  1
2000 Hayward C, Varady S, Albano AM, Thienemann M, Henderson L, Schatzberg AF. Cognitive-behavioral group therapy for social phobia in female adolescents: results of a pilot study. Journal of the American Academy of Child and Adolescent Psychiatry. 39: 721-6. PMID 10846306 DOI: 10.1097/00004583-200006000-00010  1
2000 Green AI, Tohen M, Patel JK, Banov M, DuRand C, Berman I, Chang H, Zarate C, Posener J, Lee H, Dawson R, Richards C, Cole JO, Schatzberg AF. Clozapine in the treatment of refractory psychotic mania. The American Journal of Psychiatry. 157: 982-6. PMID 10831480 DOI: 10.1176/appi.ajp.157.6.982  1
2000 Hirschfeld RM, Montgomery SA, Keller MB, Kasper S, Schatzberg AF, Möller HJ, Healy D, Baldwin D, Humble M, Versiani M, Montenegro R, Bourgeois M. Social functioning in depression: a review. The Journal of Clinical Psychiatry. 61: 268-75. PMID 10830147  1
2000 DeBattista C, Solvason HB, Breen JA, Schatzberg AF. Pramipexole augmentation of a selective serotonin reuptake inhibitor in the treatment of depression. Journal of Clinical Psychopharmacology. 20: 274-5. PMID 10770475  0.52
1999 Martel FL, Hayward C, Lyons DM, Sanborn K, Varady S, Schatzberg AF. Salivary cortisol levels in socially phobic adolescent girls. Depression and Anxiety. 10: 25-7. PMID 10499186 DOI: 10.1002/(SICI)1520-6394(1999)10:1<25::AID-DA4>3.0.CO;2-O  1
1999 Lindley SE, Bengoechea TG, Schatzberg AF, Wong DL. Glucocorticoid effects on mesotelencephalic dopamine neurotransmission. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 21: 399-407. PMID 10457537 DOI: 10.1016/S0893-133X(98)00103-1  1
1999 Schatzberg AF, DeBattista C. Phenomenology and treatment of agitation. The Journal of Clinical Psychiatry. 60: 17-20. PMID 10418809  0.52
1999 Lindley SE, Bengoechea TG, Wong DL, Schatzberg AF. Strain differences in mesotelencephalic dopaminergic neuronal regulation between Fischer 344 and Lewis rats. Brain Research. 832: 152-8. PMID 10375661 DOI: 10.1016/S0006-8993(99)01446-8  1
1999 Lyons DM, Wang OJ, Lindley SE, Levine S, Kalin NH, Schatzberg AF. Separation induced changes in squirrel monkey hypothalamic-pituitary-adrenal physiology resemble aspects of hypercortisolism in humans. Psychoneuroendocrinology. 24: 131-42. PMID 10101722 DOI: 10.1016/S0306-4530(98)00065-1  1
1999 Posener JA, Schatzberg AF, Williams GH, Samson JA, McHale NL, Bessette MP, Schildkraut JJ. Hypothalamic-pituitary-adrenal axis effects on plasma homovanillic acid in man. Biological Psychiatry. 45: 222-8. PMID 9951570 DOI: 10.1016/S0006-3223(97)00550-7  1
1998 Schatzberg AF, Samson JA, Rothschild AJ, Bond TC, Regier DA. McLean Hospital depression research facility: early-onset phobic disorders and adult-onset major depression. The British Journal of Psychiatry. Supplement. 29-34. PMID 9829014  1
1998 DeBattista C, Sofuoglu M, Schatzberg AF. Serotonergic synergism: the risks and benefits of combining the selective serotonin reuptake inhibitors with other serotonergic drugs. Biological Psychiatry. 44: 341-7. PMID 9755356  0.52
1998 Posener JA, Schildkraut JJ, Williams GH, Schatzberg AF. Late feedback effects of hypothalamic-pituitary-adrenal axis hormones in healthy subjects. Psychoneuroendocrinology. 23: 371-83. PMID 9695137 DOI: 10.1016/S0306-4530(98)00006-7  1
1998 Lyons DM, Kim S, Schatzberg AF, Levine S. Postnatal foraging demands alter adrenocortical activity and psychosocial development. Developmental Psychobiology. 32: 285-91. PMID 9589217 DOI: 10.1002/(SICI)1098-2302(199805)32:4<285::AID-DEV3>3.0.CO;2-J  1
1997 Debattista C, Solvason HB, Belanoff J, Schatzberg AF. Treatment of psychotic depression. The American Journal of Psychiatry. 154: 1625-6. PMID 9356580  0.52
1997 Posener JA, Schildkraut JJ, Williams GH, Schatzberg AF. Cortisol feedback effects on plasma corticotropin levels in healthy subjects. Psychoneuroendocrinology. 22: 169-76. PMID 9203227 DOI: 10.1016/S0306-4530(96)00046-7  1
1997 Shiang J, Blinn R, Bongar B, Stephens B, Allison D, Schatzberg A. Suicide in San Francisco, CA: a comparison of Caucasian and Asian groups, 1987-1994. Suicide & Life-Threatening Behavior. 27: 80-91. PMID 9112726  1
1996 Posener JA, Schildkraut JJ, Samson JA, Schatzberg AF. Diurnal variation of plasma cortisol and homovanillic acid in healthy subjects. Psychoneuroendocrinology. 21: 33-8. PMID 8778902 DOI: 10.1016/0306-4530(95)00033-X  1
1995 Kornstein SG, Schatzberg AF, Yonkers KA, Thase ME, Keitner GI, Ryan CE, Schlager D. Gender differences in presentation of chronic major depression. Psychopharmacology Bulletin. 31: 711-8. PMID 8851644  1
1995 Salzman C, Wolfson AN, Schatzberg A, Looper J, Henke R, Albanese M, Schwartz J, Miyawaki E. Effect of fluoxetine on anger in symptomatic volunteers with borderline personality disorder. Journal of Clinical Psychopharmacology. 15: 23-9. PMID 7714224 DOI: 10.1097/00004714-199502000-00005  1
1995 Debattista C, Schatzberg AF. Physical symptoms associated with paroxetine withdrawal. The American Journal of Psychiatry. 152: 1235-4. PMID 7625481  0.52
1994 Albanese MJ, Bartel RL, Bruno RF, Morgenbesser MW, Schatzberg AF. Comparison of measures used to determine substance abuse in an inpatient psychiatric population. The American Journal of Psychiatry. 151: 1077-8. PMID 8010367  1
1994 Posener JA, Schildkraut JJ, Williams GH, Gleason RE, Salomon MS, Mecheri G, Schatzberg AF. Acute and delayed effects of corticotropin-releasing hormone on dopamine activity in man. Biological Psychiatry. 36: 616-21. PMID 7833428 DOI: 10.1016/0006-3223(94)90074-4  1
1993 Green AI, Alam MY, Sobieraj JT, Pappalardo KM, Waternaux C, Salzman C, Schatzberg AF, Schildkraut JJ. Clozapine response and plasma catecholamines and their metabolites. Psychiatry Research. 46: 139-49. PMID 8483973 DOI: 10.1016/0165-1781(93)90016-A  1
1993 Rothschild AJ, Samson JA, Bond TC, Luciana MM, Schildkraut JJ, Schatzberg AF. Hypothalamic-pituitary-adrenal axis activity and 1-year outcome in depression. Biological Psychiatry. 34: 392-400. PMID 8218607 DOI: 10.1016/0006-3223(93)90184-F  1
1992 Kane JM, Evans DL, Fiester SJ, Mirin SM, Pincus HA, Schatzberg AF, Cole JO, Popper CW. Psychopharmacological screening criteria. APA Committee on Research on Psychiatric Treatments. The Journal of Clinical Psychiatry. 53: 184-96. PMID 1607347  1
1992 Schildkraut JJ, Schatzberg AF, Samson JA, Rosenbaum A, Bowden CL. Norepinephrine output and metabolism in depressed patients during antidepressant treatments. Clinical Neuropharmacology. 15: 323A-324A. PMID 1498855  1
1991 Schatzberg AF, Ballenger JC. Decisions for the clinician in the treatment of panic disorder: when to treat, which treatment to use, and how long to treat. The Journal of Clinical Psychiatry. 52: 26-31; discussion 32. PMID 1995599  1
1991 Mooney JJ, Schatzberg AF, Cole JO, Samson JA, Waternaux C, Gerson B, Pappalardo KM, Schildkraut JJ. Urinary 3-methoxy-4-hydroxyphenylglycol and the depression-type score as predictors of differential responses to antidepressants. Journal of Clinical Psychopharmacology. 11: 339-43. PMID 1770151  1
1990 Schatzberg AF, Samson JA, Rothschild AJ, Luciana MM, Bruno RF, Bond TC. Depression secondary to anxiety: findings from the McLean Hospital Depression Research Facility. The Psychiatric Clinics of North America. 13: 633-49. PMID 2281010  1
1989 Schatzberg AF, Samson JA, Bloomingdale KL, Orsulak PJ, Gerson B, Kizuka PP, Cole JO, Schildkraut JJ. Toward a biochemical classification of depressive disorders. X. Urinary catecholamines, their metabolites, and D-type scores in subgroups of depressive disorders. Archives of General Psychiatry. 46: 260-8. PMID 2783211 DOI: 10.1001/archpsyc.1989.01810030066009  1
1989 Teicher MH, Glod CA, Aaronson ST, Gunter PA, Schatzberg AF, Cole JO. Open assessment of the safety and efficacy of thioridazine in the treatment of patients with borderline personality disorder. Psychopharmacology Bulletin. 25: 535-49. PMID 2631134  1
1988 Mooney JJ, Schatzberg AF, Cole JO, Kizuka PP, Salomon M, Lerbinger J, Pappalardo KM, Gerson B, Schildkraut JJ. Rapid antidepressant response to alprazolam in depressed patients with high catecholamine output and heterologous desensitization of platelet adenylate cyclase. Biological Psychiatry. 23: 543-59. PMID 2833319 DOI: 10.1016/0006-3223(88)90002-9  1
1987 Schatzberg AF, Rothschild AJ, Langlais PJ, Lerbinger JE, Schildkraut JJ, Cole JO. Psychotic and nonpsychotic depressions: II. Platelet MAO activity, plasma catecholamines, cortisol, and specific symptoms. Psychiatry Research. 20: 155-64. PMID 3575560 DOI: 10.1016/0165-1781(87)90007-2  1
1986 Bond TC, Rothschild AJ, Lerbinger J, Schatzberg AF. Delusional depression, family history, and DST response: a pilot study. Biological Psychiatry. 21: 1239-46. PMID 3756274 DOI: 10.1016/0006-3223(86)90306-9  1
1985 Samson JA, Gudeman JE, Schatzberg AF, Kizuka PP, Orsulak PJ, Cole JO, Schildkraut JJ. Toward a biochemical classification of depressive disorders--VIII. Platelet monoamine oxidase activity in subtypes of depressions. Journal of Psychiatric Research. 19: 547-55. PMID 4078757 DOI: 10.1016/0022-3956(85)90072-X  1
1985 Schatzberg AF, Rothschild AJ, Gerson B, Lerbinger JE, Schildkraut JJ. Toward a biochemical classification of depressive disorders IX. DST results and platelet MAO activity. The British Journal of Psychiatry : the Journal of Mental Science. 146: 633-7. PMID 4016477  1
1985 Mooney JJ, Schatzberg AF, Cole JO, Kizuka PP, Schildkraut JJ. Enhanced signal transduction by adenylate cyclase in platelet membranes of patients showing antidepressant responses to alprazolam: preliminary data. Journal of Psychiatric Research. 19: 65-75. PMID 2985777 DOI: 10.1016/0022-3956(85)90069-X  1
1985 Mooney JJ, Cole JO, Schatzberg AF, Gerson B, Schildkraut JJ. Pretreatment urinary MHPG levels as predictors of antidepressant responses to alprazolam. The American Journal of Psychiatry. 142: 366-7. PMID 2857533  1
1984 Hudson JI, Hudson MS, Rothschild AJ, Vignati L, Schatzberg AF, Melby JC. Abnormal results of dexamethasone suppression tests in nondepressed patients with diabetes mellitus. Archives of General Psychiatry. 41: 1086-9. PMID 6497571 DOI: 10.1001/archpsyc.1983.01790220076012  1
1984 Schatzberg AF, Rothschild AJ, Bond TC, Cole JO. The DST in psychotic depression: diagnostic and pathophysiologic implications. Psychopharmacology Bulletin. 20: 362-4. PMID 6473631  1
1983 Schatzberg AF, Rothschild AJ, Stahl JB, Bond TC, Rosenbaum AH, Lofgren SB, MacLaughlin RA, Sullivan MA, Cole JO. The dexamethasone suppression test: identification of subtypes of depression. The American Journal of Psychiatry. 140: 88-91. PMID 6847992  1
1983 Rosenbaum AH, Maruta T, Schatzberg AF, Orsulak PJ, Jiang NS, Cole JO, Schildkraut JJ. Toward a biochemical classification of depressive disorders, VII: urinary free cortisol and urinary MHPG in depressions. The American Journal of Psychiatry. 140: 314-8. PMID 6829802  1
1983 Rosenbaum AH, Schatzberg AF, Jost FA, Cross PD, Wells LA, Jiang NS, Maruta T. Urinary free cortisol levels in anxiety. Psychosomatics. 24: 835-7. PMID 6647727 DOI: 10.1016/S0033-3182(83)73157-9  1
1983 Schatzberg AF, Orsulak PJ, Rothschild AJ, Salomon MS, Lerbinger J, Kizuka PP, Cole JO, Schildkraut JJ. Platelet MAO activity and the dexamethasone suppression test in depressed patients. The American Journal of Psychiatry. 140: 1231-3. PMID 6614239  1
Show low-probability matches.